Related Experiment Video
Updated: May 15, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
[Magnetic resonance imaging of hypertrophic cardiomyopathy : evaluation of diastolic function]
F Schwarz1, F Schwab, B M Beckmann
1Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Campus Grosshadern, Deutschland. Florian.Schwarz@med.uni-muenchen.de
Insights
Hypertrophic cardiomyopathy (HCM) diagnosis relies on imaging. This study compared cardiac function and wall thickness in patients with and without diastolic dysfunction, crucial for assessing HCM progression.
Area of Science:
- Cardiology
- Medical Imaging
Context:
- Hypertrophic cardiomyopathy (HCM) affects ~0.2% of the population, often presenting asymptomatically or with non-specific symptoms.
- Accurate diagnosis and clinical course assessment of HCM are vital, with myocardial hypertrophy (ventricular wall thickness ≥ 15 mm) being the definitive finding.
- Echocardiography serves as a screening tool, while cardiac magnetic resonance imaging (MRI) provides comprehensive analysis of HCM, including hypertrophy extent, cardiac function, outflow tract obstruction, and mitral valve dynamics.
Purpose:
- To compare systolic functional parameters and end-systolic/diastolic wall thickness in patients with and without diastolic dysfunction within the context of HCM.
- To highlight the role of advanced imaging, particularly MRI, in evaluating HCM complexity.
Summary:
- This study investigated differences in systolic function and ventricular wall thickness between hypertrophic cardiomyopathy patients with and without diastolic dysfunction.
- Cardiac MRI offers detailed insights into HCM, including hypertrophy, function, obstruction, and fibrosis, aiding in patient management.
Impact:
- Provides a comparative analysis of key cardiac parameters in HCM patients with varying diastolic function.
- Emphasizes the utility of cardiac MRI in the detailed assessment and management of hypertrophic cardiomyopathy.
Abstract:
Hypertrophic cardiomyopathy (HCM) has a prevalence of approximately 0.2% and is clinically asymptomatic in many patients or presents with unspecific symptoms. This explains the importance of imaging for the diagnosis of HCM as well as for the assessment of the clinical course. The definitive finding in HCM is myocardial hypertrophy with thickening of the ventricular wall ≥ 15 mm. While echocardiography is an excellent screening tool magnetic resonance imaging (MRI) allows a comprehensive analysis of the heart in HCM. This includes a detailed analysis of the distribution and extent of myocardial hypertrophy, a thorough evaluation of systolic and diastolic cardiac function, the assessment of the presence and extent of dynamic outflow tract obstruction as well as the description of the systolic anterior motion (SAM) phenomenon of the mitral valve with secondary mitral insufficiency. When contrast material is administered, additional information about myocardial perfusion as well as the presence and extent of myocardial fibrosis can be obtained. This study compared systolic functional parameters as well as end systolic and end diastolic wall thickness of patients with and without diastolic dysfunction.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System IV: CMRI
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure II: Pathophysiology

